Structures of Glycoprotein Ibα and Its Complex with von Willebrand Factor A1 Domain
Eric G. Huizinga, Shizuko Tsuji, Roland A. Romijn, Marion E. Schiphorst, Philip G. de Groot, Jan J. Sixma, Piet Gros
Abstract
Open-access reader
Eric G. Huizinga, Shizuko Tsuji, Roland A. Romijn, Marion E. Schiphorst, Philip G. de Groot, Jan J. Sixma, Piet Gros
Abstract
Open-access reader
Transient interactions of platelet-receptor glycoprotein Ibalpha (GpIbalpha) and the plasma protein von Willebrand factor (VWF) reduce platelet velocity at sites of vascular damage and play a role in haemostasis and thrombosis. Here we present structures of the GpIbalpha amino-terminal domain and its complex with the VWF domain A1. In the complex, GpIbalpha wraps around one side of A1, providing two contact areas bridged by an area of solvated charge interaction. The structures explain the effects of gain-of-function mutations related to bleeding disorders and provide a model for shear-induced activation. These detailed insights into the initial interactions in platelet adhesion are relevant to the development of antithrombotic drugs.
OpenAlex reports 554 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Transient interactions of platelet-receptor glycoprotein Ibalpha (GpIbalpha) and the plasma protein von Willebrand factor (VWF) reduce platelet velocity at sites of vascular damage and play a role in haemostasis and thrombosis. Here we present structures of the GpIbalpha amino-terminal domain and its complex with the VWF domain A1. In the complex, GpIbalpha wraps around one side of A1, providing two contact areas bridged by an area of solvated charge interaction. The structures explain the effects of gain-of-function mutations related to bleeding disorders and provide a model for shear-induced activation. These detailed insights into the initial interactions in platelet adhesion are relevant to the development of antithrombotic drugs.
Key concepts: Von Willebrand factor, Glycoprotein Ib, Platelet Glycoprotein GPIb-IX Complex, Platelet, Glycoprotein, Platelet membrane glycoprotein, Chemistry, Receptor